Clinical Trial Update: Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation [Phase 3]

View source ↗

Summary

This trial update describes a Phase 3 study evaluating Thymoglobulin (anti-thymocyte globulin) in unrelated donor hematopoietic progenitor cell transplantation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: McMaster University | Conditions: Hematologic Malignancies | Phase 3 | Status: UNKNOWN